FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1859693609> ?p ?o ?g. }

• W1859693609 abstract "[Author Affiliation]Kendra J. Grim. 1 Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota.Philip R. Fischer. 2 Department of Pediatrics, Mayo Clinic, Rochester, Minnesota.Jason S. Eldrige. 1 Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota.Address correspondence to: Kendra J. Grim, MD, 200 First Street SW, Rochester MN 55905, E-mail: grim.kendra@mayo.eduTo The Editor:Diphenhydramine has been considered a relatively safe medication, with multiple indications. Common uses in pediatrics include sedation and treatment of pruritus and nausea. Many hospitalized children and adolescents receive intravenous diphenhydramine. Anecdotally, adolescents report a very pleasant feeling with rapid intravenous infusion and sometimes request administration this way for the high they experience. Actual abuse of repeated intravenous diphenhydramine has only very rarely been reported.Case ReportA 22-year-old female was admitted to our hospital for evaluation of a possible intra-abdominal abscess following transplanted kidney removal at an outside institution. She had a history of three prior renal transplants, the first occurring at 3 years of age. Her latest transplanted kidney failed>1 year prior, and she was dependent on intermittent hemodialysis. Psychiatric consultation diagnosed her with a mood disorder secondary to her medical condition, and did not find an Axis II diagnosis. Global Assessment of Functioning was rated to be 50-55. Input from a pain medicine specialist was requested for acute or chronic abdominal pain management. The patient was requesting intravenous diphenhydramine 50 mg every 4 hours for pruritus provoked by multiple triggers, including narcotics, intravenous antibiotics, blood transfusion, and dialysis. Historically, she had been treated with intravenous diphenhydramine starting at 8 years of age, with initial doses of 25 mg intravenously. At her current outpatient hemodialysis appointments (three times weekly), she received one 50 mg intravenous dose prior to the start of dialysis, and a second 50 mg dose at the conclusion of each dialysis session.While hospitalized, she requested that diphenhydramine be administered while she was awake to observe the administration, and demanded that rapid intravenous injection be followed by saline flush. She became visibly upset when she was not awoken for her scheduled diphenhydramine doses. After observing this behavior, the intravenous diphenhydramine was discontinued, and she was offered oral diphenhydramine to treat pruritus instead. She subsequently displayed further anger, stating I demand to have my IV Benadryl. When told that intravenous delivery was no longer indicated, she denied secondary or euphoric effects of diphenhydramine. Although she was offered oral diphenhydramine to treat pruritus, and prevent withdrawal, she continued to demand intravenous diphenhydramine. She threatened to refuse intravenous antibiotics and dialysis. The patient was not listed for renal transplant for multiple reasons, including the need for further testing such as stress echocardiogram, vascular computed tomography study, and Pap smear. The patient's demand for diphenhydramine was also listed as requiring treatment prior to transplantation.After hospital discharge, the patient did not complete the required testing for transplantation at our institution, and did not return follow-up phone calls. Notification of her death was received, having occurred 10 months after her hospital discharge. The cause of death was not available.The patient had consented to research via Minnesota Research Authorization, and institutional review board (IRB) approval was obtained.DiscussionDiphenhydramine is a first generation antihistamine of the ethanolamine family. A competitive inhibitor of H1-receptors, diphenhydramine also has anticholinergic/antimuscarinic and antiserotonergic activity. …" @default.
• W1859693609 created "2016-06-24" @default.
• W1859693609 creator A5002004254 @default.
• W1859693609 creator A5004886277 @default.
• W1859693609 creator A5035024612 @default.
• W1859693609 date "2015-10-01" @default.
• W1859693609 modified "2023-09-26" @default.
• W1859693609 title "Inadvertent Iatrogenic Misuse of Intravenous Diphenhydramine in an Adolescent: Implications for Routine Medication Administration" @default.
• W1859693609 cites W157022601 @default.
• W1859693609 cites W1963521710 @default.
• W1859693609 cites W1970428489 @default.
• W1859693609 cites W1973330712 @default.
• W1859693609 cites W1983416909 @default.
• W1859693609 cites W1991784287 @default.
• W1859693609 cites W2015563832 @default.
• W1859693609 cites W2042798946 @default.
• W1859693609 cites W2067970495 @default.
• W1859693609 cites W2071410393 @default.
• W1859693609 cites W2077704084 @default.
• W1859693609 cites W2092233423 @default.
• W1859693609 cites W2122287561 @default.
• W1859693609 cites W2124957646 @default.
• W1859693609 cites W2161089729 @default.
• W1859693609 cites W2409179302 @default.
• W1859693609 doi "https://doi.org/10.1089/cap.2012.0103" @default.
• W1859693609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25076382" @default.
• W1859693609 hasPublicationYear "2015" @default.
• W1859693609 type Work @default.
• W1859693609 sameAs 1859693609 @default.
• W1859693609 citedByCount "1" @default.
• W1859693609 countsByYear W18596936092021 @default.
• W1859693609 crossrefType "journal-article" @default.
• W1859693609 hasAuthorship W1859693609A5002004254 @default.
• W1859693609 hasAuthorship W1859693609A5004886277 @default.
• W1859693609 hasAuthorship W1859693609A5035024612 @default.
• W1859693609 hasConcept C1122143 @default.
• W1859693609 hasConcept C118552586 @default.
• W1859693609 hasConcept C126322002 @default.
• W1859693609 hasConcept C141071460 @default.
• W1859693609 hasConcept C187212893 @default.
• W1859693609 hasConcept C2776814716 @default.
• W1859693609 hasConcept C2780580376 @default.
• W1859693609 hasConcept C2780724011 @default.
• W1859693609 hasConcept C2780852908 @default.
• W1859693609 hasConcept C2780955771 @default.
• W1859693609 hasConcept C2781292560 @default.
• W1859693609 hasConcept C42219234 @default.
• W1859693609 hasConcept C61434518 @default.
• W1859693609 hasConcept C71924100 @default.
• W1859693609 hasConceptScore W1859693609C1122143 @default.
• W1859693609 hasConceptScore W1859693609C118552586 @default.
• W1859693609 hasConceptScore W1859693609C126322002 @default.
• W1859693609 hasConceptScore W1859693609C141071460 @default.
• W1859693609 hasConceptScore W1859693609C187212893 @default.
• W1859693609 hasConceptScore W1859693609C2776814716 @default.
• W1859693609 hasConceptScore W1859693609C2780580376 @default.
• W1859693609 hasConceptScore W1859693609C2780724011 @default.
• W1859693609 hasConceptScore W1859693609C2780852908 @default.
• W1859693609 hasConceptScore W1859693609C2780955771 @default.
• W1859693609 hasConceptScore W1859693609C2781292560 @default.
• W1859693609 hasConceptScore W1859693609C42219234 @default.
• W1859693609 hasConceptScore W1859693609C61434518 @default.
• W1859693609 hasConceptScore W1859693609C71924100 @default.
• W1859693609 hasLocation W18596936091 @default.
• W1859693609 hasLocation W18596936092 @default.
• W1859693609 hasOpenAccess W1859693609 @default.
• W1859693609 hasPrimaryLocation W18596936091 @default.
• W1859693609 isParatext "false" @default.
• W1859693609 isRetracted "false" @default.
• W1859693609 magId "1859693609" @default.
• W1859693609 workType "article" @default.